Luciole Medical, a Swiss medical technology company, agreed to acquire Spiegelberg, a medical device company, from SHS Capital, an independent private equity company. Financial terms were not disclosed. "We have known the Spiegelberg team and products for a long time and were impressed by the quality of the business they have built. This strategic acquisition will allow us to accelerate the accessibility of our products in Europe and prepare for the market launch of our innovative brain monitoring technologies in the US. We at Luciole believe that brain monitoring is an important tool both in the operating room and the intensive care setting to understand the pathologies linked to a fundamental but poorly understood organ," Philippe Dro, Luciole CEO.